Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Duarte

Showing results (811-820 of 824) with videos related to

Pageof 83
Sort By:
Medical Microbiology and Immunology|April 19, 2021
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasisRafaella R Costa, João A Oliveira-da-Silva, Thiago A R Reis, et al.
Parasite (Paris, France)|May 1, 2020
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine modelGrasiele S V Tavares, Débora V C Mendonça, Isabela A G Pereira, et al.
Molecular Immunology|June 26, 2020
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasisJoão A Oliveira-da-Silva, Daniela P Lage, Fernanda F Ramos, et al.
Experimental Parasitology|December 30, 2021
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary studyDébora V C Mendonça, Grasiele S V Tavares, Isabela A G Pereira, et al.
Experimental Parasitology|July 6, 2020
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human diseaseAmanda S Machado, Fernanda F Ramos, Thaís T O Santos, et al.
Cellular Immunology|November 13, 2017
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Acta Tropica|December 25, 2019
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasisAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Immunology Letters|January 26, 2020
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Parasitology Research|June 15, 2020
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cellsPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Scientific Reports|February 2, 2018
Human migration and the spread of malaria parasites to the New WorldPriscila T Rodrigues, Hugo O Valdivia, Thais C de Oliveira, et al.
Pageof 83

Showing results (811-820 of 824) with videos related to

Sort By:
Pageof 83
Medical Microbiology and Immunology|April 19, 2021
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasisRafaella R Costa, João A Oliveira-da-Silva, Thiago A R Reis, et al.
Parasite (Paris, France)|May 1, 2020
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine modelGrasiele S V Tavares, Débora V C Mendonça, Isabela A G Pereira, et al.
Molecular Immunology|June 26, 2020
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasisJoão A Oliveira-da-Silva, Daniela P Lage, Fernanda F Ramos, et al.
Experimental Parasitology|December 30, 2021
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary studyDébora V C Mendonça, Grasiele S V Tavares, Isabela A G Pereira, et al.
Experimental Parasitology|July 6, 2020
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human diseaseAmanda S Machado, Fernanda F Ramos, Thaís T O Santos, et al.
Cellular Immunology|November 13, 2017
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Acta Tropica|December 25, 2019
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasisAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Immunology Letters|January 26, 2020
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Parasitology Research|June 15, 2020
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cellsPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Scientific Reports|February 2, 2018
Human migration and the spread of malaria parasites to the New WorldPriscila T Rodrigues, Hugo O Valdivia, Thais C de Oliveira, et al.
Pageof 83